Cencora, Inc. $COR Shares Acquired by Bank of Montreal Can

Bank of Montreal Can lifted its position in Cencora, Inc. (NYSE:COR) by 9.2% during the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 261,869 shares of the company’s stock after acquiring an additional 22,020 shares during the period. Bank of Montreal Can owned 0.14% of Cencora worth $81,842,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other hedge funds have also modified their holdings of the company. IAG Wealth Partners LLC purchased a new position in Cencora during the 3rd quarter worth approximately $30,000. Vermillion & White Wealth Management Group LLC raised its holdings in shares of Cencora by 69.4% during the second quarter. Vermillion & White Wealth Management Group LLC now owns 105 shares of the company’s stock worth $31,000 after purchasing an additional 43 shares during the last quarter. Cloud Capital Management LLC purchased a new position in shares of Cencora during the third quarter worth $31,000. Caitlin John LLC purchased a new position in shares of Cencora during the 3rd quarter valued at about $31,000. Finally, Westside Investment Management Inc. lifted its holdings in shares of Cencora by 200.0% in the 3rd quarter. Westside Investment Management Inc. now owns 105 shares of the company’s stock valued at $33,000 after buying an additional 70 shares during the period. 97.52% of the stock is owned by institutional investors and hedge funds.

Insider Activity at Cencora

In related news, EVP Elizabeth S. Campbell sold 3,351 shares of the company’s stock in a transaction that occurred on Friday, December 19th. The stock was sold at an average price of $342.10, for a total value of $1,146,377.10. Following the transaction, the executive vice president directly owned 23,891 shares in the company, valued at approximately $8,173,111.10. This represents a 12.30% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Also, CEO Robert P. Mauch sold 5,096 shares of the stock in a transaction on Tuesday, January 20th. The stock was sold at an average price of $354.73, for a total value of $1,807,704.08. Following the transaction, the chief executive officer owned 66,726 shares of the company’s stock, valued at approximately $23,669,713.98. This represents a 7.10% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Over the last 90 days, insiders sold 15,220 shares of company stock valued at $5,282,867. 0.38% of the stock is currently owned by insiders.

Cencora Stock Down 0.6%

COR stock opened at $350.15 on Thursday. Cencora, Inc. has a 52 week low of $251.94 and a 52 week high of $377.54. The company has a quick ratio of 0.51, a current ratio of 0.92 and a debt-to-equity ratio of 3.62. The firm has a 50-day simple moving average of $355.08 and a 200-day simple moving average of $337.60. The stock has a market capitalization of $68.12 billion, a P/E ratio of 42.09, a P/E/G ratio of 1.64 and a beta of 0.68.

Cencora (NYSE:COR) last posted its quarterly earnings data on Wednesday, February 4th. The company reported $4.08 earnings per share (EPS) for the quarter, topping the consensus estimate of $4.04 by $0.04. Cencora had a return on equity of 176.54% and a net margin of 0.50%.The company had revenue of $85.93 billion for the quarter, compared to analysts’ expectations of $86.12 billion. During the same period in the previous year, the firm posted $3.73 EPS. Cencora’s revenue was up 5.5% compared to the same quarter last year. Equities analysts forecast that Cencora, Inc. will post 15.37 earnings per share for the current fiscal year.

Cencora Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Monday, March 2nd. Investors of record on Friday, February 13th were paid a dividend of $0.60 per share. This represents a $2.40 annualized dividend and a yield of 0.7%. The ex-dividend date of this dividend was Friday, February 13th. Cencora’s dividend payout ratio is currently 28.85%.

Wall Street Analysts Forecast Growth

Several research firms recently commented on COR. Robert W. Baird set a $415.00 target price on Cencora in a report on Tuesday, January 13th. Wall Street Zen downgraded Cencora from a “buy” rating to a “hold” rating in a report on Friday, November 28th. Evercore lowered their price objective on Cencora from $440.00 to $420.00 and set an “outperform” rating on the stock in a research report on Thursday, February 5th. JPMorgan Chase & Co. increased their price target on shares of Cencora from $417.00 to $419.00 and gave the stock an “overweight” rating in a report on Tuesday, February 10th. Finally, Wells Fargo & Company raised their price target on shares of Cencora from $405.00 to $429.00 and gave the company an “overweight” rating in a research report on Tuesday, February 10th. Eleven research analysts have rated the stock with a Buy rating and two have given a Hold rating to the stock. Based on data from MarketBeat.com, Cencora has an average rating of “Moderate Buy” and an average price target of $399.00.

About Cencora

Cencora (NYSE:COR) is a global healthcare services and pharmaceutical distribution company that provides end-to-end solutions across the pharmaceutical supply chain. The company’s core activities include wholesale drug distribution, specialty drug distribution, and the operation of specialty pharmacies, complemented by logistics, cold-chain management and other fulfillment services designed to support complex and temperature-sensitive therapies.

Beyond physical distribution, Cencora offers a range of commercial and patient-focused services for pharmaceutical manufacturers and healthcare providers.